コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ere treated with high-dose three-dimensional conformal radiotherapy.
2 f predicting outcome after three-dimensional conformal radiotherapy.
3 diotherapy, which continued until the end of conformal radiotherapy.
4 al than that achieved with three-dimensional conformal radiotherapy (3D CRT), allowing dose reduction
5 , new technologies such as three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated e
8 edulloblastoma or PNET patients treated with conformal radiotherapy and HDC are typically transient a
9 ated conformal techniques (three-dimensional conformal radiotherapy and intensity-modulated radiother
10 o define the maximally accelerated course of conformal radiotherapy and to describe the short-term an
11 t irradiation delivered by three-dimensional conformal radiotherapy are affected by treatment techniq
12 ts with NSCLC treated with three-dimensional conformal radiotherapy at Memorial Sloan-Kettering Cance
13 ment may be achieved with dose escalation in conformal radiotherapy, by the addition of cytotoxic che
16 ears of follow-up showed that escalated-dose conformal radiotherapy improved biochemical progression-
17 ted conformal radiotherapy with control-dose conformal radiotherapy in patients with localised prosta
20 a randomized clinical trial of stereotactic conformal radiotherapy (SCRT) compared with conventional
21 n low-grade gliomas, stereotactically guided conformal radiotherapy should lead to a significant redu
22 nt chemotherapy, hypoxic-cell modifiers, and conformal radiotherapy, so that care of patients with no
23 nagement of these patients, including use of conformal radiotherapy, stereotactic body radiation ther
24 ce for application of stereotactic and other conformal radiotherapy techniques in treating brain tumo
25 ion, ethnic origin, sex, age when undergoing conformal radiotherapy, total radiotherapy dose, number
26 re randomly assigned (1:1) to receive either conformal radiotherapy (up to 50.4 Gy; 28 doses of 1.8 G
28 apy is an advanced form of three-dimensional conformal radiotherapy which allows delivery of high dos
29 n therapy for 3-6 months before the start of conformal radiotherapy, which continued until the end of
30 urvival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and
31 of this trial was to compare dose-escalated conformal radiotherapy with control-dose conformal radio
32 median follow-up of 10 years, escalated-dose conformal radiotherapy with neoadjuvant androgen depriva
33 atients treated with immediate postoperative conformal radiotherapy (without delay or chemotherapy),
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。